A
Name | Dosage form | ATC code |
---|---|---|
![]() Alpha-tocopherol acetate (vitamin E) Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 20 ml № 1 | A11HA03 |
![]() Alpha-tocopherol acetate (vitamin E) Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
100 mg/ml, 20 ml № 1 | A11HA03 |
![]() Alpha-tocopherol acetate (vitamin E) Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
300 mg/ml, 20 ml № 1 | A11HA03 |
![]() Aquavit-D3 Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
375 mcg/ml, 10 ml № 1 | A11CC05 |
![]() Ascorbic acid Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
25 mg №50 | A11GA01 |
![]() Ascorbic acid Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
25 mg № 100 | A11GA01 |
![]() Ascorbic acid Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg № 50 | A11GA01 |
![]() Ascorbic acid Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 2 ml № 10, № 100 | A11GA01 |
![]() Ascorbic acid Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
100 mg/ml, 2 ml № 10, № 100 | A11GA01 |
![]() Bisacodyl Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,01 g № 10 | A06AB02 |
![]() Carbacid Pechaevskiy Chewable tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A02AX |
![]() Dalmaxin Suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,2 g № 5, № 10 | A05BA |
![]() Diosmectite Powder for oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
3,0 g №10 | A07BC05 |
![]() Ergocalciferol (vitamin D2) Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,125 %, 10 ml № 1 | A11CC01 |
![]() Glibenclamide Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
5 mg № 30 | А10ВВ01 |
![]() Heksavit Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 50 | A11BA |
![]() Kreazim 10000 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
![]() Kreazim 20000 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
![]() Lactulose Syrup Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
670 mg/ml 100 ml | A06AD11 |
![]() Lactulose Syrup Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
670 mg/ml 200 ml | A06AD11 |
|
2 ml № 5 | А11DВ |
![]() Leksadyl Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
10 mg № 10 | А06АВ02 |
![]() Lektac Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg № 10, № 20, № 30 | A02BA02 |
![]() Loperamide Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,002 g № 10, № 20 | A07DA03 |
![]() Methovitan Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 hard capsules | А11АВ |
![]() Methyluracil Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,5 g, № 5 ,№ 10 | A14B |
![]() Nevrolek Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 ml № 5 | A11DB |
![]() No-H-Sha Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,04 g № 10 | A03AD02 |
![]() No-H-Sha Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,04 g № 10, № 30 | A03A D02 |
![]() No-H-Sha Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 mg/mg, 2 ml in ampoules № 5 | A03AD02 |
![]() No-H-Sha forte Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,08 g № 30 | A03AD02 |
![]() Ondansetron Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 mg/ml 2 ml № 5 | A04AA01 |
![]() Ondansetron Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 mg/ml 4 ml № 5 | A04AA01 |
![]() Ondansetron Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
4 mg № 10 | A04AA01 |
![]() Ondansetron Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
8 mg № 10 | A04AA01 |
![]() Pancreatin 8000 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, №50 | A09AA02 |
![]() Pancreazim Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | A09AA02 |
![]() Pancreazim 10000 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
![]() Pancreazim 10000 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
![]() Papaverine Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 mg/ml, 2 ml № 10 | A03AD01 |
![]() Pyridoxine hydrochloride (vitamin В6) Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml № 10 | A11HA02 |
![]() Ranitidine Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg №30 | A02BA02 |
![]() Ranitidine Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg № 20 | A02BA02 |
![]() Renalgan Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 10 | A03DA02 |
![]() Renalgan Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 ml №10 | A03DA02 |
![]() Renalgan Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№20 | A03DA02 |
![]() Renalgan Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
5 ml №5 | A03DA02 |
![]() Retinol acetate (vitamin A) Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
34,4 mg/ml, 10 ml № 1 | A11CA01 |
![]() Revit Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 75, № 100 | A11BA |
![]() Solizym forte Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA |
![]() Stomolik Solution for oral cavity Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
125 ml № 1 | А01АВ12 |
![]() Thiamine chloride (vitamin В1) Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml in ampoules № 10 | A11DA01 |
![]() Undevit Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 50 | A11BA |